Page 2 - பராமரிப்பு புற்றுநோயியல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

StageZero Life Sciences Ltd: StageZero Life Sciences Announces Q4 2020 and Year End Financial Results and Operational Update of $2.82 Million TORONTO, ON / ACCESSWIRE / April 1, 2021 / StageZero Life Sciences, Ltd. (TSX:SZLS) ( StageZero or the Company ) reports financial results for the three and twelve months ended December 31, 2020, and provides an update on its business progress. Fourth quarter revenues are up significantly from Q3 and increased more than $2.54 million compared with the fourth quarter of 2019. This builds on our third quarter results and the Company s decision to offer COVID-19 testing. The Company received $2.82 million revenue during Q4 2020, which amount included revenue deferred into 2021 of $0.23 million said James Howard-Tripp, Chairman and CEO of StageZero.

United statesJames howard trippRebecca grecoJamesr howard trippCompany contactsInternational financial reporting standardsStagezero life sciences ltdHealth clinicsIchor blood servicesStagezero life sciencesAcquisition of health clinicsIchor bloodCare oncologyInternational financial reportingZero life sciencesStage zero